These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 24703097)

  • 41. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis.
    Liu H; Zhou H; Wang J; Sun M; Teng D; Song H; Xu Q; Wei S
    J Neurol Sci; 2019 Jan; 396():225-231. PubMed ID: 30522039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
    O'Connell K; Hamilton-Shield A; Woodhall M; Messina S; Mariano R; Waters P; Ramdas S; Leite MI; Palace J
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1126-1128. PubMed ID: 32576617
    [No Abstract]   [Full Text] [Related]  

  • 43. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L; Vignal Clermont C; Deschamps R
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases.
    Wang C; Narayan R; Greenberg B
    Pediatr Neurol; 2018 Sep; 86():42-45. PubMed ID: 30077551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies.
    Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ
    Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases.
    Hofer LS; Ramberger M; Gredler V; Pescoller AS; Rostásy K; Sospedra M; Hegen H; Berger T; Lutterotti A; Reindl M
    Front Immunol; 2020; 11():1188. PubMed ID: 32625206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
    Cobo-Calvo A; Sepúlveda M; d'Indy H; Armangué T; Ruiz A; Maillart E; Papeix C; Audoin B; Zephir H; Biotti D; Ciron J; Durand-Dubief F; Collongues N; Ayrignac X; Labauge P; Thouvenot E; Montcuquet A; Deschamps R; Solà-Valls N; Llufriu S; Blanco Y; de Seze J; Vukusic S; Saiz A; Marignier R; ;
    J Neurol; 2019 Apr; 266(4):806-815. PubMed ID: 30607536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
    Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
    JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Indirect Immunofluorescence-Aided Detection of Antimyelin Oligodendrocyte Glycoprotein Antibodies in Neuromyelitis Optica Spectrum Disorder/Myelin Oligodendrocyte Glycoprotein-Associated Antibody Disorder: A Case Series Involving Five Patients.
    Datta D; Mahto M; Sinha U; Kumar S
    Ann Afr Med; 2024 Oct; 23(4):731-736. PubMed ID: 39138928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
    Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
    Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
    Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
    JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
    Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
    Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
    Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
    Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
    Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
    Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis.
    Vieira JP; Sequeira J; Brito MJ
    J Child Neurol; 2017 Oct; 32(12):996-999. PubMed ID: 28820014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
    Maillart E; Durand-Dubief F; Louapre C; Audoin B; Bourre B; Derache N; Ciron J; Collongues N; de Sèze J; Cohen M; Lebrun-Frenay C; Hadhoum N; Zéphir H; Deschamps R; Carra-Dallière C; Labauge P; Kerschen P; Montcuquet A; Wiertlewski S; Laplaud D; Runavot G; Vukusic S; Papeix C; Marignier R;
    J Neuroinflammation; 2020 Apr; 17(1):128. PubMed ID: 32326965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective.
    Chaudhuri J; Biswas T; Ganguly G; Datta S; Pandit A; Biswas A
    Acta Neurol Belg; 2021 Aug; 121(4):927-931. PubMed ID: 32314270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.